Archive: 02/09/2014

Hopes dashed for an agent to prevent reperfusion injury

The administration of an experimental agent known as TRO40303 to patients who have had a heart attack, with the hope of preventing tissue damage when impaired blood flow is corrected (reperfusion), was disappointingly ineffective ...

page 7 from 11